An accurate exchange rate forecasting and its decision-making to buy or sell are critical issues in the Forex market. Short-term currency rate forecasting is a challenging task due to its inherent characteristics, which include high volatility, trend, noise, and market shocks. We propose a novel deep learning architecture consisting of an adaptive activation function selection mechanism to achieve higher predictive accuracy. The proposed architecture is composed of seven neural networks that have different activation functions as well as softmax layer and multiplication layer with a skip connection, which are used to generate the dynamic importance weights that decide which activation function is preferred. In addition, we introduce an extended Min-Max smoothing technique to further normalize financial time series that have non-stationary properties. In our experimental evaluation, the results showed that our proposed model not only outperforms deep neural network baselines but also other classic machine learning approaches. The extended Min-Max smoothing technique is step towards forecasting non-stationary financial time series with deep neural networks. INDEX TERMS Neural networks, activation function, value at risk, min-max normalization, forex market.
Developing lifelong learning algorithms are mandatory for computational systems biology. Recently, many studies have shown how to extract biologically relevant information from high-dimensional data to understand the complexity of cancer by taking the benefit of deep learning (DL). Unfortunately, new cancer growing up into the hundred types that make systems difficult to classify them efficiently. In contrast, the current state-of-the-art continual learning (CL) methods are not designed for the dynamic characteristics of high-dimensional data. And data security and privacy are some of the main issues in the biomedical field. This paper addresses three practical challenges for class-incremental learning (Class-IL) such as data privacy, high-dimensionality, and incremental learning problems. To solve this, we propose a novel continual learning approach, called Deep Generative Feature Replay (DGFR), for cancer classification tasks. DGFR consists of an incremental feature selection (IFS) and a scholar network (SN). IFS is used for selecting the most significant CpG sites from high-dimensional data. We investigate different dimensions to find an optimal number of selected CpG sites. SN employs a deep generative model for generating pseudo data without accessing past samples and a neural network classifier for predicting cancer types. We use a variational autoencoder (VAE), which has been successfully applied to this research field in previous works. All networks are sequentially trained on multiple tasks in the Class-IL setting. We evaluated the proposed method on the publicly available DNA methylation data. The experimental results show that the proposed DGFR achieves a significantly superior quality of cancer classification tasks with various state-of-the-art methods in terms of accuracy.
Hematopoietic cancer is a malignant transformation in immune system cells. Hematopoietic cancer is characterized by the cells that are expressed, so it is usually difficult to distinguish its heterogeneities in the hematopoiesis process. Traditional approaches for cancer subtyping use statistical techniques. Furthermore, due to the overfitting problem of small samples, in case of a minor cancer, it does not have enough sample material for building a classification model. Therefore, we propose not only to build a classification model for five major subtypes using two kinds of losses, namely reconstruction loss and classification loss, but also to extract suitable features using a deep autoencoder. Furthermore, for considering the data imbalance problem, we apply an oversampling algorithm, the synthetic minority oversampling technique (SMOTE). For validation of our proposed autoencoder-based feature extraction approach for hematopoietic cancer subtype classification, we compared other traditional feature selection algorithms (principal component analysis, non-negative matrix factorization) and classification algorithms with the SMOTE oversampling approach. Additionally, we used the Shapley Additive exPlanations (SHAP) interpretation technique in our model to explain the important gene/protein for hematopoietic cancer subtype classification. Furthermore, we compared five widely used classification algorithms, including logistic regression, random forest, k-nearest neighbor, artificial neural network and support vector machine. The results of autoencoder-based feature extraction approaches showed good performance, and the best result was the SMOTE oversampling-applied support vector machine algorithm consider both focal loss and reconstruction loss as the loss function for autoencoder (AE) feature selection approach, which produced 97.01% accuracy, 92.60% recall, 99.52% specificity, 93.54% F1-measure, 97.87% G-mean and 95.46% index of balanced accuracy as subtype classification performance measures.
Background: With advances in next-generation sequencing technologies, the bisulfite conversion of genomic DNA followed by sequencing has become the predominant technique for quantifying genome-wide DNA methylation at single-base resolution. A large number of computational approaches are available in literature for identifying differentially methylated regions in bisulfite sequencing data, and more are being developed continuously. Results: Here, we focused on a comprehensive evaluation of commonly used differential methylation analysis methods and describe the potential strengths and limitations of each method. We found that there are large differences among methods, and no single method consistently ranked first in all benchmarking. Moreover, smoothing seemed not to improve the performance greatly, and a small number of replicates created more difficulties in the computational analysis of BS-seq data than low sequencing depth. Conclusions: Data analysis and interpretation should be performed with great care, especially when the number of replicates or sequencing depth is limited.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.